REFERENCES
- Sjögren P, Thunedborg L P, Christrup L, Hansen S H, Franks J. Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long term administration? Six case histories. Acta Anaesthesiol Scandinavia 1998; 42: 1070–5
- Goetting M G, Thirman M J. Neurotoxicity of meperidine. Ann Emerg Med 1985; 14: 1007–9
- Miller R R, Jick H. Clinical effects of meperidine in hospitalized patients. J Clin Pharmacology 1978; 18: 180–9
- Kyff J V, Rice T L. Meperidine-associated seizures in a child. Clin Pharm 1990; 9(5)337–8
- Saneto R P, Fitch J A, Cohen B H. Acute neurotoxicity of meperidine in an infant. Pediatr Neurol 1996; 14: 339–41
- Lomenzo S A, Izenwasser S, Gerdes R M, Katz J L, Kopajtic T, Trudell M L. Synthesis, dopamine and serotonin transporter binding affinities of novel analogues of meperidine. Bioorg Med Chem Lett 1999; 9: 3273–6
- Graham P M, Potter J M, Paterson J. Combination monoamine oxidase inhibitor/tricyclic antidepresssants interaction. Lancet 1982; 21(8295)440, 2
- Insel T R, Roy B F, Cohen R M, Murphy D L. Possible development of the serotonin syndrome in man. Am J Psychiatry 1982; 139: 954–5
- Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997; 17: 208–21
- Skop B P, Finkelstein J A, Mareth T R, Magoon M R, Brown T M. The serotonin syndrome associated with paroxetine, an over the counter cold remedy, and vascular disease. Am J Emerg Med 1994; 12: 642–4
- Sindrup S H, Brosen K. The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 1995; 5: 335–46
- Lee D O, Lee C D. Serotonin syndrome in a child associated with erythromycin and sertraline. Pharmacotherapy 1999; 19: 894–6
- Gillman P K. Serotonin syndrome: history and risk. Fundam Clin Pharmacol 1998; 12: 482–91